Editorial

You have full text access to this OnlineOpen article

Exploiting T cell crosstalk as a vaccination strategy for rheumatoid arthritis

  1. Berent Prakken1,*,
  2. Salvatore Albani2

Article first published online: 30 JAN 2007

DOI: 10.1002/art.22317

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 56, Issue 2, pages 389–392, February 2007

Additional Information

How to Cite

Prakken, B. and Albani, S. (2007), Exploiting T cell crosstalk as a vaccination strategy for rheumatoid arthritis. Arthritis & Rheumatism, 56: 389–392. doi: 10.1002/art.22317

Author Information

  1. 1

    University Medical Center Utrecht, and Wilhelmina Children's Hospital, Utrecht, The Netherlands, and EUREKA Institute for Translational Medicine, Syracuse, Italy

  2. 2

    EUREKA Institute for Translational Medicine, Syracuse, Italy, University of California, San Diego, and Androclus Therapeutics, San Diego, California

*Department of Pediatric Immunology KC.03.063.0, University Medical Center Utrecht, PO Box 85090, 3508 GA Utrecht, The Netherlands

Publication History

  1. Issue published online: 30 JAN 2007
  2. Article first published online: 30 JAN 2007
  3. Manuscript Accepted: 29 SEP 2006
  4. Manuscript Received: 10 AUG 2006

Funded by

  • Fifth Framework Program “HSP for therapy,”
  • Dutch Arthritis Foundation
  • Dutch Organization for Scientific Research
  • NIH. Grant Numbers: 5P50-AR-44850-04, N01-AR-9-2241, 2R01-AI-41721-05, 1R01-AR-48084-01

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (51K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Berent J. Prakken, Salvatore Albani, Textbook of Pediatric Rheumatology, 2011,

    CrossRef

  2. 2
    Antonio La Cava, Modulation of autoimmunity with artificial peptides, Autoimmunity Reviews, 2010, 10, 1, 18

    CrossRef

  3. 3
    S. Ozen, C. Wallace, Editorial and introduction: new developments in paediatric rheumatic diseases, Best Practice & Research Clinical Rheumatology, 2009, 23, 5, 583

    CrossRef

  4. 4
    Eva C. Koffeman, Mark Genovese, Diane Amox, Elissa Keogh, Ernesto Santana, Eric L. Matteson, Arthur Kavanaugh, Jerry A. Molitor, Michael H. Schiff, James O. Posever, Joan M. Bathon, Alan J. Kivitz, Rodrigo Samodal, Francis Belardi, Carolyn Dennehey, Theo van den Broek, Femke van Wijk, Xiao Zhang, Peter Zieseniss, Tho Le, Berent A. Prakken, Gary C. Cutter, Salvatore Albani, Epitope-specific immunotherapy of rheumatoid arthritis: Clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial, Arthritis & Rheumatism, 2009, 60, 11
    Direct Link:
  5. 5
    S. Martínez-Pasamar, I. Martínez-Forero, P. Villoslada, Tr1 cells in the neat sighting-pole, Inmunología, 2008, 27, 2, 78

    CrossRef

  6. 6
    Martin Braddock, 11th Annual Inflammatory and Immune Diseases Drug Discovery and Development Summit, Expert Opinion on Investigational Drugs, 2007, 16, 6, 909

    CrossRef

View Full Article (HTML) Get PDF (51K)